| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 203.05B | 200.38B | 189.86B | 176.02B | 149.48B | 145.32B |
| Gross Profit | 63.03B | 62.37B | 58.96B | 56.38B | 39.96B | 47.64B |
| EBITDA | 22.19B | 21.59B | 22.51B | 24.03B | 11.79B | 9.71B |
| Net Income | 12.90B | 12.57B | 14.29B | 14.01B | 277.00M | 4.78B |
Balance Sheet | ||||||
| Total Assets | 179.43B | 183.86B | 170.75B | 164.45B | 147.94B | 158.66B |
| Cash, Cash Equivalents and Short-Term Investments | 30.49B | 34.03B | 25.40B | 25.12B | 18.65B | 26.02B |
| Total Debt | 16.18B | 12.78B | 7.48B | 10.45B | 10.10B | 16.14B |
| Total Liabilities | 67.50B | 70.07B | 64.04B | 68.63B | 59.61B | 64.91B |
| Stockholders Equity | 111.23B | 113.04B | 106.69B | 95.81B | 87.88B | 93.44B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 14.52B | 8.43B | 14.55B | 3.82B | 5.54B |
| Operating Cash Flow | 0.00 | 19.26B | 12.82B | 17.37B | 5.72B | 9.69B |
| Investing Cash Flow | 0.00 | -6.87B | -1.85B | -408.00M | -827.00M | -2.60B |
| Financing Cash Flow | 0.00 | -3.98B | -11.25B | -9.36B | -13.34B | -11.84B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | ¥5.68B | 4.84 | ― | 1.76% | 7.17% | 214.23% | |
76 Outperform | ¥183.94B | 11.81 | ― | 4.91% | 6.35% | 14.05% | |
76 Outperform | ¥10.52B | 3.04 | ― | 1.66% | 8.56% | 2690.35% | |
75 Outperform | ¥34.96B | 3.81 | ― | 3.56% | 3.03% | 160.39% | |
72 Outperform | ¥178.80B | 8.20 | ― | 3.41% | 6.17% | 61.39% | |
66 Neutral | ¥9.36B | 3.19 | ― | 2.65% | 1.11% | ― | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% |